医学
肝细胞癌
回顾性队列研究
肿瘤科
内科学
外科
作者
Mingjian Piao,Chengjie Li,Ziyue Huang,Nan Zhang,Jiongyuan Li,Yang Xu,Shuofeng Li,Shanshan Wang,Ziyu Xun,Li Zhang,Boyu Sun,Faming Zhang,Xiaobo Yang,Haitao Zhao
出处
期刊:Liver cancer
[Karger Publishers]
日期:2025-02-13
卷期号:14 (4): 456-473
被引量:4
摘要
Conversion surgery after meeting the surgical criteria during immunotherapy provides significant prognostic benefits for patients with initially unresectable HCC, demonstrating high safety and R0 resection rates. For those undergoing conversion surgery, promptly resuming the original treatment after surgery is necessary.
科研通智能强力驱动
Strongly Powered by AbleSci AI